$279 Million is the total value of Affinity Asset Advisors, LLC's 69 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 54.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BBIO | Sell | BRIDGEBIO PHARMA INC | $33,528,000 | -5.8% | 550,000 | -4.8% | 12.00% | -0.6% |
| XBI | New | SPDR SER TRput | $27,080,000 | – | 200,000 | +100.0% | 9.69% | – |
| ARKG | Sell | ARK ETF TRput | $20,813,000 | -2.3% | 225,000 | -6.2% | 7.45% | +3.0% |
| MORF | Buy | MORPHIC HLDG INC | $14,129,000 | +14.5% | 246,201 | +26.3% | 5.06% | +20.7% |
| CVAC | New | CUREVAC N Vput | $11,022,000 | – | 150,000 | +100.0% | 3.95% | – |
| VINC | Buy | VINCERX PHARMA INC | $10,890,000 | +3.9% | 838,311 | +54.4% | 3.90% | +9.6% |
| NAUT | New | NAUTILUS BIOTECHNOLOGY INC | $9,090,000 | – | 900,000 | +100.0% | 3.25% | – |
| KURA | Buy | KURA ONCOLOGY INC | $8,861,000 | -14.1% | 425,000 | +16.4% | 3.17% | -9.5% |
| NARI | Buy | INARI MED INC | $7,929,000 | +48.2% | 85,000 | +70.0% | 2.84% | +56.2% |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $7,577,000 | +125.3% | 142,418 | +83.8% | 2.71% | +137.6% |
| ARYD | ARYA SCIENCES ACQU CORP IVcl a | $7,504,000 | +2.4% | 700,000 | 0.0% | 2.69% | +7.9% | |
| XLRN | Buy | ACCELERON PHARMA INC | $6,902,000 | +13.1% | 55,000 | +22.2% | 2.47% | +19.3% |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $6,288,000 | +385.6% | 140,100 | +180.2% | 2.25% | +411.6% |
| Buy | RETROPHIN INCnote 2.500% 9/1 | $5,993,000 | +47.3% | 7,000,000 | +75.0% | 2.14% | +55.2% | |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $5,315,000 | +40.9% | 120,000 | +41.2% | 1.90% | +48.6% |
| CRIS | Sell | CURIS INC | $5,246,000 | -53.7% | 650,000 | -35.0% | 1.88% | -51.1% |
| CERE | Sell | CEREVEL THERAPEUTICS HLDNG I | $5,124,000 | +38.2% | 200,000 | -25.9% | 1.83% | +45.7% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $4,829,000 | -13.8% | 275,000 | +23.7% | 1.73% | -9.1% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCcall | $4,238,000 | – | 25,000 | +100.0% | 1.52% | – |
| OCUL | Buy | OCULAR THERAPEUTIX INC | $3,545,000 | -5.0% | 250,000 | +9.9% | 1.27% | +0.1% |
| HSAQ | Buy | HEALTH SCIENCES ACQ CORP 2 | $3,060,000 | +21.5% | 300,000 | +33.3% | 1.10% | +28.1% |
| IONS | New | IONIS PHARMACEUTICALS INCcall | $2,992,000 | – | 75,000 | +100.0% | 1.07% | – |
| MRNA | Buy | MODERNA INCcall | $2,937,000 | +348.4% | 12,500 | +150.0% | 1.05% | +373.4% |
| MSAC | New | MEDICUS SCIENCES ACQUISITION | $2,895,000 | – | 300,000 | +100.0% | 1.04% | – |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $2,824,000 | +3.8% | 200,000 | +14.3% | 1.01% | +9.4% |
| LUNG | Buy | PULMONX CORP | $2,647,000 | +28.6% | 60,000 | +33.3% | 0.95% | +35.6% |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $2,631,000 | +2.1% | 20,000 | 0.0% | 0.94% | +7.7% | |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $2,602,000 | +234.0% | 100,000 | +306.5% | 0.93% | +251.7% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $2,341,000 | -27.3% | 25,000 | -28.6% | 0.84% | -23.4% |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $2,266,000 | -36.4% | 200,000 | -33.3% | 0.81% | -33.0% |
| CYCC | CYCLACEL PHARMACEUTICALS INC | $2,250,000 | -16.7% | 380,000 | 0.0% | 0.80% | -12.3% | |
| MGNX | Buy | MACROGENICS INC | $2,149,000 | +170.0% | 80,000 | +220.0% | 0.77% | +184.8% |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $2,061,000 | -32.0% | 650,000 | -27.8% | 0.74% | -28.3% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $2,060,000 | +3.7% | 25,000 | -7.4% | 0.74% | +9.3% |
| EPIX | Sell | ESSA PHARMA INC | $2,000,000 | -23.5% | 70,000 | -22.2% | 0.72% | -19.4% |
| SDGR | New | SCHRODINGER INC | $1,890,000 | – | 25,000 | +100.0% | 0.68% | – |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $1,747,000 | +179.5% | 20,000 | +100.0% | 0.62% | +194.8% |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $1,687,000 | +198.1% | 25,000 | +150.0% | 0.60% | +214.6% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $1,672,000 | -37.6% | 50,000 | -61.5% | 0.60% | -34.1% |
| NTLA | New | INTELLIA THERAPEUTICS INC | $1,619,000 | – | 10,000 | +100.0% | 0.58% | – |
| New | GOSSAMER BIO INCnote 5.000% 6/0 | $1,605,000 | – | 2,000,000 | +100.0% | 0.58% | – | |
| LSAQ | Sell | LIFESCI ACQUISITION II CORP | $1,500,000 | -63.0% | 150,000 | -62.5% | 0.54% | -61.0% |
| CNTA | New | CENTESSA PHARMACEUTICALS PLCsponsored ads | $1,487,000 | – | 66,957 | +100.0% | 0.53% | – |
| BFLY | BUTTERFLY NETWORK INC | $1,448,000 | -14.0% | 100,000 | 0.0% | 0.52% | -9.4% | |
| GLPG | Buy | GALAPAGOS NVspon adr | $1,387,000 | +43.9% | 20,000 | +60.0% | 0.50% | +52.0% |
| CYTK | Buy | CYTOKINETICS INC | $1,385,000 | +48.9% | 70,000 | +75.0% | 0.50% | +57.0% |
| AFIB | Buy | ACUTUS MED INC | $1,358,000 | +69.3% | 80,000 | +33.3% | 0.49% | +78.7% |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $1,198,000 | -53.4% | 50,000 | -50.0% | 0.43% | -50.8% |
| CGEM | New | CULLINAN ONCOLOGY INC | $1,159,000 | – | 45,000 | +100.0% | 0.42% | – |
| MRSN | MERSANA THERAPEUTICS INC | $1,154,000 | -16.1% | 85,000 | 0.0% | 0.41% | -11.6% | |
| BCTG | BCTG ACQUISITION CORP | $1,138,000 | +2.3% | 100,000 | 0.0% | 0.41% | +7.7% | |
| PCVX | Buy | VAXCYTE INC | $1,126,000 | +89.9% | 50,000 | +66.7% | 0.40% | +100.5% |
| CEREW | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/2020 | $1,043,000 | +234.3% | 72,466 | 0.0% | 0.37% | +251.9% | |
| ZYME | Sell | ZYMEWORKS INC | $1,041,000 | -58.8% | 30,000 | -62.5% | 0.37% | -56.5% |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $972,000 | – | 15,000 | +100.0% | 0.35% | – |
| BLU | BELLUS HEALTH INC NEW | $933,000 | -19.0% | 300,000 | 0.0% | 0.33% | -14.6% | |
| QSI | New | QUANTUM SI INC | $920,000 | – | 75,000 | +100.0% | 0.33% | – |
| CHAQU | CHARDAN HEALTHCR ACQSTN 2 COunit 99/99/9999 | $819,000 | +3.8% | 75,000 | 0.0% | 0.29% | +9.3% | |
| ACHL | Buy | ACHILLES THERAPEUTICS PLCsponsored ads | $783,000 | +89.1% | 80,000 | +220.0% | 0.28% | +98.6% |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $700,000 | -14.1% | 20,000 | 0.0% | 0.25% | -9.4% | |
| HARP | Buy | HARPOON THERAPEUTICS INC | $694,000 | +66.0% | 50,000 | +150.0% | 0.25% | +74.6% |
| IMTXW | Sell | IMMATICS N.V*w exp 07/01/2020 | $654,000 | +10.8% | 190,000 | -5.0% | 0.23% | +17.0% |
| ITOS | New | ITEOS THERAPEUTICS INC | $641,000 | – | 25,000 | +100.0% | 0.23% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $632,000 | – | 10,000 | +100.0% | 0.23% | – |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $475,000 | +22.7% | 75,000 | +50.0% | 0.17% | +29.8% |
| IMVT | Sell | IMMUNOVANT INCcall | $317,000 | -71.8% | 30,000 | -57.1% | 0.11% | -70.3% |
| SKINW | New | THE BEAUTY HEALTH COMPANY*w exp 05/04/2026 | $288,000 | – | 45,000 | +100.0% | 0.10% | – |
| CVRX | New | CVRX INC | $210,000 | – | 7,500 | +100.0% | 0.08% | – |
| MSACW | New | MEDICUS SCIENCES ACQUISITION*w exp 02/12/2026 | $34,000 | – | 33,333 | +100.0% | 0.01% | – |
| ZYNE | Exit | ZYNERBA PHARMACEUTICALS INC | $0 | – | -13,285 | -100.0% | -0.02% | – |
| VSPRW | Exit | VESPER HEALTHCARE ACQSTN COR*w exp 09/30/2027 | $0 | – | -45,000 | -100.0% | -0.03% | – |
| WINT | Exit | WINDTREE THERAPEUTICS INC | $0 | – | -42,847 | -100.0% | -0.04% | – |
| EPZM | Exit | EPIZYME INC | $0 | – | -50,000 | -100.0% | -0.15% | – |
| BYSI | Exit | BEYONDSPRING INC | $0 | – | -50,000 | -100.0% | -0.19% | – |
| XFOR | Exit | X4 PHARMACEUTICALS INC | $0 | – | -75,000 | -100.0% | -0.22% | – |
| ASLN | Exit | ASLAN PHARMACEUTICALS LTDads | $0 | – | -200,000 | -100.0% | -0.23% | – |
| CCCC | Exit | C4 THERAPEUTICS INC | $0 | – | -20,000 | -100.0% | -0.25% | – |
| VINCW | Exit | VINCERX PHARMA INC*w exp 12/24/2025 | $0 | – | -218,000 | -100.0% | -0.30% | – |
| BLUE | Exit | BLUEBIRD BIO INCcall | $0 | – | -50,000 | -100.0% | -0.51% | – |
| CAPA | Exit | HIGHCAPE CAP ACQUISITION COR | $0 | – | -150,000 | -100.0% | -0.61% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -80,000 | -100.0% | -0.62% | – |
| RUBY | Exit | RUBIUS THERAPEUTICS INCcall | $0 | – | -70,000 | -100.0% | -0.63% | – |
| ASND | Exit | ASCENDIS PHARMA A/Sput | $0 | – | -20,000 | -100.0% | -0.88% | – |
| CRIS | Exit | CURIS INCcall | $0 | – | -250,000 | -100.0% | -0.96% | – |
| MSACU | Exit | MEDICUS SCIENCES ACQUISITIONunit 99/99/9999 | $0 | – | -300,000 | -100.0% | -1.00% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INCcall | $0 | – | -190,500 | -100.0% | -1.45% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -220,000 | -100.0% | -1.86% | – |
| ARYA | Exit | ARYA SCIENCES ACQUISITION CO | $0 | – | -689,000 | -100.0% | -3.22% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -50,000 | -100.0% | -3.65% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -110,000 | -100.0% | -14.80% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MORPHIC HOLDING INC | 12 | Q3 2023 | 6.9% |
| KURA ONCOLOGY INC | 12 | Q3 2023 | 7.2% |
| CELLDEX THERAPEUTICS INC NEW | 12 | Q3 2023 | 1.9% |
| IMMATICS N.V | 12 | Q3 2023 | 0.4% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.4% |
| ESTABLISHMENT LABS HLDGS INC | 11 | Q3 2023 | 8.3% |
| VINCERX PHARMA INC | 11 | Q2 2023 | 4.5% |
| ASCENDIS PHARMA A/S | 11 | Q3 2023 | 4.9% |
| CYTOKINETICS INC | 11 | Q3 2023 | 2.6% |
| INARI MED INC | 10 | Q1 2023 | 6.4% |
View Affinity Asset Advisors, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 03, 2023 | 7,477,000 | 9.2% |
View Affinity Asset Advisors, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-21 |
| 13F-HR | 2023-08-14 |
| SC 13G | 2023-07-03 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-13 |
View Affinity Asset Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.